Eton Pharmaceuticals (ETON) Tax Provisions (2023 - 2025)

Eton Pharmaceuticals has disclosed Tax Provisions across 3 years of filings, most recently posting -$69000.0 for Q4 2025.

• Tax Provisions for Q4 2025 came in at -$69000.0, down 179.31% year-over-year; the trailing twelve-month figure through Dec 2025 was $43000.0 (up 186.67% YoY), and the FY2025 annual result was $43000.0, up 186.67% from the prior year.
• Tax Provisions came in at -$69000.0 for Q4 2025 at Eton Pharmaceuticals, down from -$28000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $247000.0 in Q4 2023 to a low of -$126000.0 in Q3 2024.
• The 3-year median for Tax Provisions is $60000.0 (2024), against an average of $38125.0.
• Peak annual rise in Tax Provisions reached 77.78% in 2025, while the deepest fall reached 179.31% in 2025.
• Eton Pharmaceuticals' Tax Provisions stood at $247000.0 in 2023, then sank by 64.78% to $87000.0 in 2024, then tumbled by 179.31% to -$69000.0 in 2025.
• The last three Tax Provisions figures came in at -$69000.0 (Q4 2025), -$28000.0 (Q3 2025), and $66000.0 (Q2 2025), per Business Quant data.